Literature DB >> 25093153

Short-Term Quality-of-Life Changes after Endoscopic Pituitary Surgery Rated with SNOT-22.

Lee A Zimmer1, Ojas Shah1, Phillip V Theodosopoulos2.   

Abstract

Objective Little data exist on short-term quality-of-life (QOL) outcomes, specifically sinonasal measures, after endoscopic pituitary surgery. Design Prospective case series assessed sinonasal QOL before and after the transnasal endoscopic approach to the sella with resection of nasal cavity and sinus tissues. Setting/Participants/Main Outcome Measures A total of 39 adults scheduled to undergo resection for a pituitary mass preoperatively completed the Sinonasal Outcome Test-22 (SNOT-22). Rating various QOL issues, testing repeated postoperatively at 1 month by 37 patients and 3 months by 35 patients, was analyzed (paired Student t test). Results SNOT-22 scores (5-point scale; total: 110) averaged 23.4 preoperatively and 27.6 at 1 month but had significantly improved to 16.2 at 3 months (p = 0.03). Emotional well-being parameters (e.g., sadness, frustration, concentration, productivity, fatigue) significantly improved 3 months postoperatively (p < 0.05). Physiologic parameters (e.g., olfaction, obstruction, postnasal drainage) that had worsened at 1 month (< 0.05) then normalized at 3 months. Conclusion Total ratings for sinonasal QOL shows that SNOT scores were comparable between preoperative and 1-month testing but were improved significantly at 3 months. Individual questions showed marked improvement in emotional well-being and temporary physiologic changes after surgery. Our findings give surgeons information about what patients can expect immediately after transnasal endoscopic pituitary surgery.

Entities:  

Keywords:  endoscopy; pituitary surgery; quality of life; sphenoid sinus

Year:  2014        PMID: 25093153      PMCID: PMC4108485          DOI: 10.1055/s-0034-1372464

Source DB:  PubMed          Journal:  J Neurol Surg B Skull Base        ISSN: 2193-634X


  17 in total

1.  Olfaction.

Authors:  R L Doty
Journal:  Annu Rev Psychol       Date:  2001       Impact factor: 24.137

Review 2.  Endoscopic versus microscopic trans-sphenoidal pituitary surgery: a systematic review and meta-analysis.

Authors:  J K Goudakos; K D Markou; C Georgalas
Journal:  Clin Otolaryngol       Date:  2011-06       Impact factor: 2.597

3.  Olfactory changes after endoscopic pituitary tumor resection.

Authors:  Catherine K Hart; Phillip V Theodosopoulos; Lee A Zimmer
Journal:  Otolaryngol Head Neck Surg       Date:  2009-11-22       Impact factor: 3.497

4.  Maximizing the extent of tumor resection during transsphenoidal surgery for pituitary macroadenomas: can endoscopy replace intraoperative magnetic resonance imaging?

Authors:  Philip V Theodosopoulos; James Leach; Robert G Kerr; Lee A Zimmer; Amanda M Denny; Bharat Guthikonda; Sebastien Froelich; John M Tew
Journal:  J Neurosurg       Date:  2010-04       Impact factor: 5.115

5.  Endoscopy assisted transsphenoidal surgery for pituitary adenoma. Technical note.

Authors:  H D Jho; R L Carrau
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

6.  Olfactory outcomes after endoscopic transsphenoidal pituitary surgery.

Authors:  Brian W Rotenberg; Samantha Saunders; Neil Duggal
Journal:  Laryngoscope       Date:  2011-06-06       Impact factor: 3.325

7.  Endoscopic approach for pituitary surgery improves rhinologic outcomes.

Authors:  Scott M Graham; Tim A Iseli; Lucy H Karnell; John D Clinger; Patrick W Hitchon; Jeremy D W Greenlee
Journal:  Ann Otol Rhinol Laryngol       Date:  2009-09       Impact factor: 1.547

8.  Disease-specific impairments in quality of life during long-term follow-up of patients with different pituitary adenomas.

Authors:  Agatha A van der Klaauw; Marleen Kars; Nienke R Biermasz; Ferdinand Roelfsema; Olaf M Dekkers; Eleonora P Corssmit; Maarten O van Aken; Bas Havekes; Alberto M Pereira; Hanno Pijl; Johannes W Smit; Johannes A Romijn
Journal:  Clin Endocrinol (Oxf)       Date:  2008-04-29       Impact factor: 3.478

9.  Psychometric validity of the 22-item Sinonasal Outcome Test.

Authors:  C Hopkins; S Gillett; R Slack; V J Lund; J P Browne
Journal:  Clin Otolaryngol       Date:  2009-10       Impact factor: 2.597

Review 10.  Clinical, quality of life, and economic value of acromegaly disease control.

Authors:  A Ben-Shlomo; M C Sheppard; J M Stephens; S Pulgar; S Melmed
Journal:  Pituitary       Date:  2011-09       Impact factor: 4.107

View more
  6 in total

1.  Long-term outcomes of endoscopic endonasal approach for skull base surgery: a prospective study.

Authors:  Elena Rioja; Manuel Bernal-Sprekelsen; Karla Enriquez; Joaquim Enseñat; Ricard Valero; Matteo de Notaris; Joaquim Mullol; Isam Alobid
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-12-19       Impact factor: 2.503

2.  Sinonasal outcomes associated with the use of BioGlue® in endoscopic transsphenoidal pituitary surgery.

Authors:  Cathal John Hannan; Deirdre Nolan; Paula Corr; Michael Amoo; Daniel Murray; Seamus Looby; Mohsen Javadpour
Journal:  Neurosurg Rev       Date:  2022-01-27       Impact factor: 3.042

3.  Sinonasal Symptoms and Self-Reported Health before and after Endoscopic Pituitary Surgery-A Prospective Study.

Authors:  Tobias Hallén; Daniel S Olsson; Dan Farahmand; Daniela Esposito; Ann-Charlotte Olofsson; Sofie Jakobsson; Eva Jakobsson Ung; Pernilla Sahlstrand-Johnson; Gudmundur Johannsson; Thomas Skoglund; Henrik Bergquist
Journal:  J Neurol Surg B Skull Base       Date:  2021-02-18

4.  Bilateral Smell Preservation is Routinely Possible following Endoscopic Endonasal Approach for Sellar/Suprasellar Lesions.

Authors:  Kuan-Chung Ting; Wei-Hsin Wang; Edward C Kuan; Yung-Yang Lin; Ming-Ying Lan
Journal:  J Neurol Surg B Skull Base       Date:  2019-11-28

5.  Trends in surgery, hospital admissions and imaging for pituitary adenomas in Australia.

Authors:  Sjorjina Crowther; R Louise Rushworth; Wayne Rankin; Henrik Falhammar; Liza K Phillips; David J Torpy
Journal:  Endocrine       Date:  2017-11-04       Impact factor: 3.633

6.  Sinonasal quality of life in patients after an endoscopic endonasal surgery of a sellar tumour.

Authors:  Vlastimil Novák; L Hrabálek; J Hoza; D Pohlodek; J Macura
Journal:  Sci Rep       Date:  2021-12-02       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.